Skip to main content

Table 5 Multivariable analysis taking the global cognition after the COVID-19 period as the dependent variable

From: Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia

 

Beta

Effect size (n2)

p-value

Confidence interval

Lower

Upper

COVID-19 infection (Yes vs No)

−3.783

0.006

0.540

−16.043

8.478

Gender (Female vs Male)

0.110

0.002

0.737

−0.541

0.760

Education level (University vs complementary)

0.402

0.022

0.235

−0.268

1.072

Education level (Secondary vs complementary)

0.521

0.063

0.043

0.017

1.025

Positive PANSS

−0.018

0.004

0.601

−0.086

0.050

Negative PANSS

−0.011

0.002

0.720

−0.072

0.050

General psychopathology PANSS

−0.003

0.000

0.859

−0.031

0.026

Depression (Calgary scale)

0.021

0.001

0.775

−0.125

0.167

BACS composite score at baseline

0.027

0.000

0.920

−0.511

0.566

duration between BACS assessment

−0.121

0.007

0.516

−0.492

0.249

chlorpromazine equivalent dose

−0.003

0.018

0.278

−0.001

0.000

ADS score

−0.082

0.031

0.159

−0.196

0.033

Age

−0.044

0.033

0.147

−0.103

0.016

Autonomy (total ADL)

−0.004

0.000

0.991

−0.840

0.831

Interaction being diagnosed with COVID-19 and cognition at baseline

0.816

0.116

0.005

0.255

1.377

  1. Variables entered in the model: being diagnosed or not with COVID-19, age, gender, education level, clinical symptoms, depression, cognition at baseline, duration between cognitive assessment, chlorpromazine equivalent dose, autonomy and ADS score